Blueprint Medicines Corporation ( BPMC) - Key Metrics
Stock symbol BPMC is outdated, potentially delisted? Maybe it is available on other exchange?
BPMC Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q1 | $2.35 | $0.01 | -$0.86 | -$0.89 |
| 2024Q4 | $2.30 | -$0.79 | -$0.46 | -$0.48 |
| 2024Q3 | $2.02 | -$0.89 | -$0.22 | -$0.22 |
| 2024Q2 | $2.20 | -$0.80 | -$0.76 | -$0.81 |
| 2024Q1 | $1.56 | $1.45 | -$1.65 | -$1.67 |
BPMC Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q1 | ? | 2837.32 |
| 2024Q4 | ? | -27.76 |
| 2024Q3 | ? | -26.04 |
| 2024Q2 | ? | -34.32 |
| 2024Q1 | ? | 16.65 |
BPMC
Price: $129.46
52 week price:
Earnings Per Share: -2.51 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 807200
Ebitda: -37.3 millionMarket Capitalization: 8.4 billion